ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

COCH vs MLSS // EV/EBITDA & P/E VALUATION

Envoy Medical Inc. (Class A) (NASDAQ) VS. Milestone Scientific Inc. (NYSE) • 15-METRIC TALLY: COCH 3 — MLSS 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COCH VS. MLSS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC COCH MLSS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 71.40% -101.40 MLSS /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — -10.27% — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% 63.80% -123.80 MLSS /net-margins <GO>
Revenue Growth (YoY) 7.10% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 3.62% 0.00% +3.62 COCH /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 MLSS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.8 31.1 +19.70 COCH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 4.7x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $50.3M $28.6M $21.8M COCH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR COCH REV MLSS REV COCH GROSS % MLSS GROSS % COCH FCF MLSS FCF
FY 2025 $241.0K $9.0M -50.0% 71.4% -$18.4M -$2.9M
FY 2024 $225.0K $8.6M -50.0% 74.6% -$18.9M -$2.9M
FY 2023 $316.0K $0 — — -$17.1M -$5.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COCH // BETA —
MLSS // BETA —